These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1079922)

  • 1. Lysis mediated by T cells and restricted by H-2 antigen of target cells infected with vaccinia virus.
    Koszinowski U; Ertl H
    Nature; 1975 Jun; 255(5509):552-4. PubMed ID: 1079922
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytotoxic interactions of virus specific effector cells with virus infected targets of different cell type.
    Koszinowski U; Ertl H
    J Immunogenet; 1977 Apr; 4(2):107-14. PubMed ID: 194984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells.
    Koszinowski U; Thomssen R
    Eur J Immunol; 1975 Apr; 5(4):245-51. PubMed ID: 1086229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of early viral surface antigens in cellular immune response to vaccinia virus.
    Koszinowski U; Ertl H
    Eur J Immunol; 1976 Oct; 6(10):679-83. PubMed ID: 65141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cells that express viral antigens but lack H-2 determinants are not lysed by immune thymus-derived lymphocytes but are lysed by other antiviral immune attack mechanisms.
    Zinkernagel RM; Oldstone MB
    Proc Natl Acad Sci U S A; 1976 Oct; 73(10):3666-70. PubMed ID: 1086476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of H-2 antigenic sites by enzymatic treatment influences virus-specific target cell lysis.
    Ertl HC; Koszinowski UH
    J Immunol; 1976 Dec; 117(6):2112-8. PubMed ID: 993596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of alterations induced by early vaccinia surface antigens and dependence of virus-specific lysis on H-2 antigen concentration on target cells.
    Koszinowski U; Ertl H; Wekerle H; Thomssen R
    Cold Spring Harb Symp Quant Biol; 1977; 41 Pt 2():529-37. PubMed ID: 302176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatally tolerant mice fail to react against virus-infected tolerated cells.
    Zinkernagel RM; Callahan GN; Streilein JW; Klein J
    Nature; 1977 Apr; 266(5605):837-9. PubMed ID: 301251
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of capping H-2 antigens on the susceptibility of target cells to humoral and T cell-mediated lysis.
    Ekidin M; Henney CS
    Nat New Biol; 1973 Nov; 246(150):47-9. PubMed ID: 4202329
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytes.
    Perrin LH; Zinkernagel RM; Oldstone MB
    J Exp Med; 1977 Oct; 146(4):949-69. PubMed ID: 302316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1.
    Wong CY; Woodruff JJ; Woodruff JF
    J Immunol; 1977 Apr; 118(4):1159-64. PubMed ID: 300399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antigen density on complement-mediated lysis, T-cell-mediated killing, and antigenic modulation.
    Lesley J; Hyman R; Dennert G
    J Natl Cancer Inst; 1974 Dec; 53(6):1759-65. PubMed ID: 4140238
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccinia virus proteins on the plasma membranes of infected cells. II. Expression of viral antigens and killing of infected cells by vaccinia virus-specific cytotoxic T cells.
    Mallon VR; Domber EA; Holowczak JA
    Virology; 1985 Aug; 145(1):1-23. PubMed ID: 3874471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inductive requirements for the generation of virus-specific T lymphocytes. III. Production of target cells lysable by poxvirus-specific and allospecific cytotoxic T lymphocytes with membrane fragments bearing viral and H-2 antigens.
    Hapel AJ; Bablanian R; Cole GA
    J Immunol; 1980 Apr; 124(4):1997-2003. PubMed ID: 6154088
    [No Abstract]   [Full Text] [Related]  

  • 15. Susceptibility of anti-H-2-capped target cells to humoral and T lymphocyte-mediated lysis.
    Stulting RD; Todd RF; Gooding LR
    Transplantation; 1976 Jan; 21(1):71-3. PubMed ID: 1082189
    [No Abstract]   [Full Text] [Related]  

  • 16. H-2 restriction of virus-specific cytotoxicity across the H-2 barrier. Separate effector T-cell specificities are associated with self-H-2 and with the tolerated allogeneic H-2 in chimeras.
    Zinkernagel RM
    J Exp Med; 1976 Oct; 144(4):933-45. PubMed ID: 62016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered serological and cellular reactivity to H-2 antigens after target cell infection with vaccinia virus.
    Koszinowski U; Ertl H
    Nature; 1975 Oct; 257(5527):596-7. PubMed ID: 52122
    [No Abstract]   [Full Text] [Related]  

  • 18. H-2 compatibility requirement for virus-specific T-cell-mediated cytolysis. The H-2K structure involved is coded by a single cistron defined by H-2Kb mutant mice.
    Zinkernagel RM
    J Exp Med; 1976 Feb; 143(2):437-43. PubMed ID: 1082490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H-2 compatibility requirement for virus-specific T-cell-mediated cytolysis. Evaluation of the role of H-2I region and non-H-2 genes in regulating immune response.
    Zinkernagel RM; Dunlop MB; Blanden RV; Doherty PC; Shreffler DC
    J Exp Med; 1976 Aug; 144(2):519-32. PubMed ID: 1085331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response against vaccinia virus in rhesus monkeys: no evidence for primary MHC-restricted cytolytic T cells.
    Stitz L; Zinkernagel R; Balch CM; Bolhuis RL; Balner H
    Exp Cell Biol; 1984; 52(4):237-50. PubMed ID: 6610578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.